Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NOVOS is a private consumer longevity biotechnology company focused on translating aging research into clinically studied products and tools intended to support healthspan and slow biological aging. The company markets longevity nutraceuticals such as NOVOS Core, Boost, Vital, and Bar, and also offers NOVOS Age, an at-home biological age blood test based on epigenetic analysis. NOVOS positions itself as a science-driven platform targeting multiple hallmarks or mechanisms of aging through multi-ingredient formulations rather than a traditional prescription-drug pipeline. Its business spans consumer health products, longevity diagnostics, and broader aging-related bioinformatics and AI-enabled research efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NOVOS.